DocuSign Q1 2026 Earnings EPS Beat Drives Modest Stock Gain Lisata Therapeutics LSTA Q3 2025 Earnings EPS Beat Drives Positive Stock Reaction EYPT Q1 2026 Earnings EPS Misses Estimates as Clinicalstage Biotech Advances Pipeline SXT Q1 2026 Earnings Strong EPS Beat Driven by Margin Improvement BNR Q3 2022 Earnings NarrowerThanExpected Loss as Biotech Company Navigates Challenges CDRE Q1 2026 Earnings EPS Miss Amid Operational Challenges Stock Rises 158